Effects of tranexamic acid on the recovery of osteochondral defects treated by microfracture and acellular matrix scaffold: an experimental study

Recent improvements in the field of science and medicine during the last decade lead to a prolongation of lifespan and increase the importance of sports in human life. However, the frequency of traumatic and degenerative cartilage injuries increases, making the treatment strategies more important in the meantime. Untreated cartilage and osteochondral injuries resulting with severe pain, restricted movements, and deterioration in the quality of life may proceed to diffuse intracartilage damage and osteoarthritis in which major surgical procedures are mandatory for treatment [1].

Intrinsic activity and regeneration ability of cartilage tissue is extremely limited [2]. Cellular migration to this area is restricted due to the density and the avascularity of the tissue. Thus, there is a lack of cell and mediator transfer from adjacent subchondral and synovial tissues to the damaged area, leading to an insufficient recovery of the isolated cartilage and osteochondral tissues [3].

Methods that are used for the recovery of the cartilage tissue can be summarized as microfracture and scaffold procedures, progenitor cell-seeded scaffold procedures, otolog chondrocyte culture, and implantations [4]. However, there are further studies ongoing to obtain the original hyaline cartilage tissue. The most common method in clinical practice is the microfracture and scaffold implantation procedures due to its favorable cost and successful results of the experimental studies [4].

Materials that are used in the experimental design of scaffolds include collagen, hyaluronic acid (HA), polylactide, fibrinogen, and hydroxyapatite which are bioabsorbable [5]. Hyaluronic acid-based biomaterials are the most favorable materials due to their ability to bind CD44 surface receptors of chondrocytes or mesenchymal stem cells. Moreover, they are responsible for the production of the extracellular matrix of the direct chondrogenic genes [6]. Various biomaterials such as natural polymers like collagen, agarose, and hyaluronan or synthetic polymers like polylactic acid, polyglycolic acid, or the components of both are experimentally or clinically in use, still [7‐9]. Hyaluronan is a non-immunogenic, biocompatible, and soluble macromolecular polysaccharide which is formed by the repetition of N-acetyl-D-glucosamine and D-glucuronic units. Non-crosslinked scaffolds are more soluble due to their affinity to water and their breakage via hyaluronidase enzyme [10].

The success of this procedure can be attributed to the stability of the clot on the scaffold, and its suitability as a host for the progenitor cells arising from subchondral tissue following microfracture, leading to an improvement of regenerating tissue [11‐13].

Tranexamic acid is a synthetic antifibrinolytic agent in the stabilization of fibrin via inhibiting the plasminogen activation which is very popular in orthopedic surgery by decreasing the amount of bleeding after major surgeries [14, 15]. It can both be applied topically and by intravenous route. However, topical usage is more favorable due to the possible side effects and safety issues of intravenous administration [16].

Regarding our literature knowledge about TA as a fibrin stabilizer, we aimed to investigate the effects of intraarticular TA application on the recovery of experimental osteochondral lesions following microfracture and a-cellular scaffold application.

This study was carried out with the approval of the local ethics committee of animal research of Abant Izzet Baysal University (AIBU) with the decision numbered 08.03.2017/11. European laws on animal experimentation were strictly followed throughout the study, and the animal experimental protocol was approved as requested by Turkey Law according to EC rules (Law by Decree, 2010/63/EU). The popular method in cartilage repair techniques using biomaterials with small experimental animals is to create a defect in femoral condyles and trochlea. Rabbits represent a species, which is very suitable to test newly advanced biomaterials or new therapies as they can be handled easily, are relatively inexpensive, and offer a good joint size for surgical procedures. Larger animals, like, e.g., sheep or goats, are relatively more expensive and reasonably considered to be used in later preclinical studies [17]. New Zealand white rabbit is a type that is suitable for the durability tests of the traditional regulatory committee and is recommended in the ISO 10993 guidelines. Eighteen rabbits weighing 2500 g for 4 months were obtained from the experimental animal care center of AIBU with the support of Duzce University Scientific Research Projects Support Fund. Production and growing of animals and experimental study were made in the same center. The animals were maintained at 20 ± 3 °C with a relative humidity of 40–60% and a photoperiod of 12/12 h, light and dark. Each rabbit was housed in a cage of stainless steel with the bottom grid. The animals were fed with a pellet diet and had access to tap water continuously.

In total, 18 subjects were enrolled in the study. None had any wound infection or death. Slight edema and swelling were observed in the knee joint regions of all subjects in the first 7 days. During the sacrification, all defect-forming areas were macroscopically distinguishable from the surrounding cartilage tissue and no synovitis or infective tissue was detected on the surgical site.

Macroscopic examination of tissue samples taken at fourth week postoperatively showed that both groups of lesions were filled with repair tissue. At the eighth week, all lesions were completely covered with regeneration tissue. Grade 2 nearly normal recovery was observed in three samples taken from group 1 in the fourth week; however, this improvement was not observed in any of the specimens in the group 2. In the control group, grade 4 severely abnormal level was seen in one specimen, while other samples were observed to be repaired with an abnormal level of grade 3. Grade 1 improvement was observed in one sample in group 1, and other samples were detected as grade 2 in the eighth week. On the other hand, in group 2, five samples were grade 2 and four samples were grade 3. In particular, the lesion site in the group 1 was more homogeneous (Additional file 1).

Histopathologically, it was found that the regeneration rate of subchondral tissue in the group 1 was higher when compared with group 2 at the fourth week. Moreover, the onset of cartilage tissue regeneration was observed in some subjects of group 1. Complete subchondral tissue regeneration was achieved in both groups at the end of eighth week. There was no original cartilage tissue regeneration in the groups. However, cartilage tissue repair rate and hyaline cartilage tissue ratio were found to be higher in group 1, when compared with group 2 at the eighth week (Fig. 2) (Table 1).

Osteochondral injuries are challenging clinical issues but also an area of interest in terms of recent material improvement and surgical innovations. Prior cartilage treatment researches revealed debridement, abrasion, and drilling methods while current improvements revised the definition of microfracture methods [24‐26]. The initial description of the microfracture technique was reported by Stedman and colleagues in 1994, which is still in use for the treatment of osteochondral lesions with successful results of 11-year follow-ups [27, 28]. Microfracture technique can be considered as the first-line treatment for osteochondral lesions due to the cost-effectivity, single session application availability, and the short- and middle-term successful results of the method. However, the long-term efficacy of the method is still under debate.

A previous prospective study reported that 65% of young athletes under the age of 40 who underwent microfracture returned to sports, and this rate was found 20% in the elder patients [29]. After 2 years, the clinic worsened in all groups and the results were found to be worsened earlier, if the joint cartilage was exposed to early weight bearing. Gudas et al. demonstrated that surface fibrillation and fibrocartilage tissues were the dominant tissues in the areas of repair which were treated with microfracture technique in the 3-year follow-ups of young athletes [30].

Histological evaluation of experimental studies demonstrated a dominant fibrocartilage structure with a lesser hyaline cartilage feature in the regeneration tissue. The major contributor to this complex structure was found to be lack of an unavailable extracellular environment for the mesenchymal cells to differentiate and for the regeneration tissue to stabilize [29‐31]. As a common determination of these studies, early weight bearing prior to the maintenance of appropriate regeneration tissue leads to a damage in cartilage healing. We aimed to maintain a more rapid and stabilized regeneration tissue to avoid poor outcomes.

Recently, three-dimensional cell implants with chondroconductive and osteoconductive properties produced from synthetic and biological materials by tissue engineers have a favorable clinical preference in order to prevent stabilization problems of the repaired tissue [31]. Among these, HA structured scaffolds which are bioavailable and bioabsorbable with a chemical structure suitable for the covalent binding of chondrocytes are favorable implants. Moreover, they facilitate collagen (types 1 and 2) production from mesenchymal stem cells via TGF that improves chondrogenic improvement [31]. Thus, we also preferred HA-structured a-cellular scaffolds in our study.

Demonstrating the benefits of HA structured scaffolds, Siclari et al. reported that 52 patients between the ages of 25 and 65 treated who were treated with microfracture and HA scaffold had significantly better clinical scores. Among these, the histological evaluations of the biopsies of 13 patients revealed a homogenous hyaline-like cartilage repair tissue [11]. A previous study of Gill et al. showed clinical healing of 87% on the osteochondral lesions with the 3.4 cm² width after microfracture and scaffold implantation at the 27-month follow-up of 27 patients [24].

In the mid-term results of various clinical studies, the superiority of microfracture and scaffold application compared to microfracture is presented clinically and radiologically [32‐34]. Erggelet et al. histologically reported the superiority of microfracture and cell-free scaffold application according to microfracture, and it was suggested to use microfracture together with scaffold in clinical applications in the damage of the full layer small cartilage defects [12]. Goyal et al. showed that younger patients and small lesions tend to have a better prognosis in the first 5 years, but osteoarthritis developed in all lesions after 5 years (30). Since microfracture and scaffold applications are shown to be insufficient in the formation of solid cartilage tissue against weight bearing on the knee joint [35], we planned to design this study.

Autologous chondrocyte implantation (ACI) has become prominent in recent years. In the study of Knutsen et al. in 2007, no significant difference was found between ACI and microfracture in 2 and 5 years follow-up retrospectively [36]. No significant difference was found between the ACI and microfracture in major chronic defects in the 14–15-year follow-up results of the same team [37, 38]. Although this method was reported to be the best treatment option in acute and large lesions of young active patients, its clinical use is limited due to it being a two-step surgery, high cost, not recommended to elderly patients, and with similar results according to microfracture in the early period of small defects.

More recently, TA is a popular molecule in orthopedic surgery which is frequently used for the prevention of perioperative and postoperative complications by decreasing the amount of bleeding during knee surgery [39]. Considering the mechanism of action, it is an effective molecule for the stabilization of fibrin [40]. In a previous study of Ambra and colloquies, no dose-dependent negative effect on cartilage viability was reported when TA was applied topically [19]. However, Parker and colloquies revealed that increasing the concentrations of TA above 20 mg/ml in vitro is associated with increased chondrocyte death. Suggesting the dose-dependent damage of TA, Turtle et al. showed that TA was found to be cytotoxic to bovine and murine cartilage at the dose of 100 mg/mL; however, the safety cutoff dose was found to be 25 mg/ml for TA [41, 42].

In our study, in order to form a more stable and fast fibrin clot in the regeneration area, TA was used intraarticularly, and more stable fibrin tissue formation and rapid regeneration were observed in microscopic and macroscopic evaluations. The mean scores obtained at the end of the fourth week were significantly higher in group 1, and it was observed that regeneration started more rapidly in the samples in this group, the repair tissue became more resistant to external forces in a shorter time, and cartilage repair started more rapidly in the eighth week.

Macroscopic results of our study revealed that the regularity of the surface was smoother and the tissue stability was more robust with higher mean Brittberg scores in group 1 when compared with group 2, both at the fourth and eighth weeks. Moreover, subchondral tissue and cartilage tissue regenerations were found to be more rapid and organized in group 1 without any negative effects on mesenchymal cells in microscopic evaluations. Suggesting our results, a previous experimental study reported that TA does not have a negative effect on chondrocyte viability and extracellular cell matrix production at appropriate doses in vitro [19].

To conclude, in our study, we reported that TA clearly improved the healing of osteochondral defects which are treated by microfracture and a-cellular scaffold when applied intraarticularly with a significant improvement of healing time and quality of repair tissue. Thus, our findings were compatible with our hypothesis, stating that TA possibly improves the healing time and tissue stability in osteochondral defects which are treated by microfracture and a-cellular scaffold application. However, further long-term experimental and clinical studies are needed to demonstrate the original cartilage regeneration.